- Report
- June 2026
- 140 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- May 2026
- 350 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- January 2026
- 150 Pages
Global
From €3534EUR$3,950USD£3,022GBP
- Report
- August 2026
- 199 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 184 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- January 2026
- 191 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 281 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 364 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- May 2026
- 180 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Clinical Trials
- May 2026
- 80 Pages
Global
From €1790EUR$2,000USD£1,530GBP
- Report
- March 2026
- 200 Pages
Global
From €2495EUR$2,789USD£2,134GBP
- Report
- May 2026
- 200 Pages
Global
From €2495EUR$2,789USD£2,134GBP
- Report
- January 2026
- 148 Pages
Global
From €3534EUR$3,950USD£3,022GBP
- Report
- October 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- June 2026
- 116 Pages
Global
From €4161EUR$4,650USD£3,558GBP
- Report
- July 2025
- 150 Pages
Global
From €5324EUR$5,950USD£4,553GBP
- Report
- December 2024
- 150 Pages
Global
From €5324EUR$5,950USD£4,553GBP
- Report
- August 2025
- 120 Pages
United States
From €3534EUR$3,950USD£3,022GBP
- Report
- October 2023
- 145 Pages
Global
From €2818EUR$3,150USD£2,410GBP

Opioid Use Disorder (OUD) is a type of addiction disorder that is characterized by the compulsive use of opioids, such as heroin, morphine, and prescription painkillers. OUD is a serious public health issue, with an estimated 2.1 million people in the United States suffering from the disorder. OUD is associated with a range of physical and psychological health problems, including an increased risk of overdose, infectious diseases, and mental health issues. Treatment for OUD typically involves a combination of medication-assisted treatment (MAT) and psychosocial interventions. MAT involves the use of medications, such as buprenorphine and methadone, to reduce cravings and withdrawal symptoms. Psychosocial interventions include cognitive-behavioral therapy, motivational interviewing, and 12-step programs.
Companies in the OUD market include Indivior, Alkermes, Orexo, and Braeburn Pharmaceuticals. Show Less Read more